1,734 Spam-Free Article(s) Found
Symbol Name Last Close Mkt Cap DailyStocks'
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Monday’s Close
MRK Merck & Company, Inc. $70.42 $187.28B Buy
Article Searches
Wall Street Breakfast: Fed's Stress Tests - Part 2 https://seekingalpha.com/article/4084447-wall-street-breakfast-feds-stress-tests-part-2?source=feed_all_articles Jun 28, 2017 - The second-leg of the Fed's annual bank stress tests will be released today. The CCAR scores will determine whether the 34 largest U.S. financial institutions can go ahead with their capital distribu
Lung Cancer Patients Live Longer With Immune Therapy https://www.nytimes.com/2018/04/16/health/lung-cancer-immunotherapy.html?partner=rss&emc=rss Apr 16, 2018 - Adding immunotherapy to standard chemo treatments can halve the risk of death for people with the most common type of lung cancer, a new study shows.
So Merck Just Made History. Should You Care As An Investor? https://seekingalpha.com/article/4077023-merck-just-made-history-care-investor?source=feed_all_articles May 28, 2017 - Merck recently got the first-ever drug approval that is tumor agnostic.While the approval doesn't cast as wide a net as it may seem at first, it could pay dividends.The impact on clinical oncology cou
Anavex Life Sciences: 5 Reasons Why I'm Short https://seekingalpha.com/article/4074451-anavex-life-sciences-5-reasons-short?source=feed_tag_short_ideas May 19, 2017 - Anavex is trying to cure an intractable disease, and its competitors are formidable.Anavex's trials have been too small to attach any efficacy significance.Moreover its data has been inconsistent, she
Sky's The Limit For Ziopharm https://seekingalpha.com/article/4094186-skys-limit-ziopharm?source=feed_sector_healthcare Aug 03, 2017 - Ziopharm is moving into a pivotal trial for the Ad-RTS-hIL-12 + Veledimex treatment for Glioblastoma ((GBM)).The progression with the Point-of-Care therapy using CD19 specific CAR-T cells continues in
BLS Reports Robust July Jobs: 255K, 4.9% Unemployment http://www.zacks.com/stock/news/227064/bls-reports-robust-july-jobs-255k-49-unemployment?cid=CS-ZC-FT-227064 Aug 05, 2016 - Also, May's paltry 11K jobs was more than doubled to 24K, and even June's strong 287K rose another 5000 jobs to 292K.
BioLineRx: Expands Cancer Pipeline Significantly By Acquiring Novel Drug Candidate Ready For Human Trials https://seekingalpha.com/article/4058198-biolinerx-expands-cancer-pipeline-significantly-acquiring-novel-drug-candidate-ready-human?source=feed_tag_israel Mar 27, 2017 - The company announced on March 23, 2017, the acquisition of UK-based private oncology company Agalimmune for $6M in cash and stock.Agalimmune's lead drug candidate AGI-134 boosts the immune system, ki
Morningstar: This Large Biotech Could Be The World's Best Stock https://seekingalpha.com/article/4067441-morningstar-large-biotech-worlds-best-stock?source=feed May 01, 2017 - Roche, the Swiss biotech and lab diagnostics giant, reported a strong but unremarkable Q1 recently.A mainstream stock analytic house, Morningstar, last week rated it as its #1 healthcare stock globall
3 Things In Biotech You Should Learn Today: April 24, 2017 https://seekingalpha.com/article/4064492-3-things-biotech-learn-today-april-24-2017?source=feed_all_articles Apr 24, 2017 - Atara hatching a collaboration with Merck in head and neck cancer immunotherapy.Galmed makes a case for its own NASH drug in Europe.Biosimilar rituximab continues to gain momentum in Europe.
Ablynx - Catalyst Next Month, Good Midterm Buy https://seekingalpha.com/article/4106482-ablynx-catalyst-next-month-good-midterm-buy?source=feed_all_articles Sep 13, 2017 - Ablynx is preparing for a potential first launch of its lead drug candidate caplacizumab in 1H2018, with phase 3 data readout possibly next month.Ablynx has more than 45 proprietary and partnered prog

Pages: 123456...174

Page 1>

Related Companies

Name Exchange Price Mkt Cap
NVS Novartis AG NYSE $85.13 $197.65B
ABBV AbbVie Inc. NYSE $95.37 $144.42B
PFE Pfizer, Inc. NYSE $43.01 $252.13B
ABT Abbott Laboratories NYSE $67.67 $118.71B
NVO Novo Nordisk A/S NYSE $47.64 $114.84B
Sector: Health Care > Industry: Major Pharmaceuticals
DeepLinks for Merck & Company
MRK - Google Finance https://www.google.com/finance?q=MRK Industry related info and international coverage Summary News
MRK - Bloomberg http://www.bloomberg.com/research/stocks/snapshot/snapshot.asp?ticker=MRK Original news and commentary from Bloomberg Charts Financials with pensions Snapshot Earnings Transactions People Options